CME
CME Group Inc
271.20$
-0.5%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.6% | +3.4% | +3.0% | +3.4% | -3.7% | +7.7% | +3.0% | -9.1% | +7.2% | +14.0% | -9.2% | – | |
| – | +3.6% | -3.2% | -0.6% | +6.9% | +0.9% | -6.4% | +7.2% | +7.2% | +1.5% | -7.5% | +135.3% | – | |
| – | +8.3% | +4.5% | +3.6% | +2.8% | -4.5% | +10.0% | +2.4% | -11.6% | +8.3% | +17.7% | -28.7% | – | |
| – | +5.2% | +1.5% | +7.9% | +3.9% | – | – | – | – | – | – | – | – | |
| – | +12.1% | -8.3% | +4.8% | -10.7% | +9.4% | -15.9% | +31.2% | -1.9% | +30.5% | -41.1% | +3.2% | – | |
| – | +16.4% | -11.3% | +1.5% | +4.3% | +4.7% | -8.3% | +4.1% | -4.0% | +18.5% | -10.5% | -78.6% | – | |
| – | +5.2% | +11.2% | +4.3% | +2.4% | -7.5% | +17.0% | +1.9% | -13.9% | +4.8% | +28.5% | -15.5% | – | |
| – | +0.3% | +0.5% | +0.5% | +0.2% | +1.2% | +2.5% | +5.5% | +0.0% | -0.7% | -0.2% | +0.0% | – | |
| – | +3.3% | +10.7% | +3.7% | +1.9% | -6.8% | +13.5% | +6.9% | -11.5% | +34.1% | -4.3% | -12.1% | – | |
| – | -14.6% | +34.9% | +5.1% | -2.7% | -15.9% | +30.0% | +5.8% | -11.9% | +52.6% | -13.1% | -19.8% | – | |
| – | +8.6% | +5.0% | +3.3% | +3.4% | -4.2% | +9.3% | +5.9% | -10.3% | +28.6% | -1.2% | -9.7% | – | |
| – | +2.7% | +9.4% | +3.2% | +1.7% | -6.2% | +12.1% | +6.5% | -10.6% | +22.0% | +3.0% | -49.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.